"primary_key","object_id","product_family_id","product_family_name","product_family_number","laststreameddate","edms_number","artifact_name","file_type","compound_asset","ctd_section","ectd_leaf_title","country_or_region","itemgroup","sub_group","generic_name","trade_names","compound_name","status"
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e5ccf-725d-7665-8879-b4e5edf1c434-1234-$record.itemnumber","018e5ccf-725d-7665-8879-b4e5edf1c434","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1245431,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,"amivantamab,amivantamab","NOT AVAILABLE,RYBREVANT,NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA,JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e61f5-cc62-7cde-ac86-dd589a1c6fbb-1234-$record.itemnumber","018e61f5-cc62-7cde-ac86-dd589a1c6fbb","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269151,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-8170-780c-9257-217368a91ab2-1234-$record.itemnumber","018e6c42-8170-780c-9257-217368a91ab2","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269041,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,JNJ-61186372-AAA,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-8188-70a1-97ce-ca896ee634da-1234-$record.itemnumber","018e6c42-8188-70a1-97ce-ca896ee634da","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269091,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-8197-744b-97ba-f205789d6222-1234-$record.itemnumber","018e6c42-8197-744b-97ba-f205789d6222","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269061,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-81ad-73cc-9171-99372f76023d-1234-$record.itemnumber","018e6c42-81ad-73cc-9171-99372f76023d","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269031,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-81c4-79eb-823c-9419139e1090-1234-$record.itemnumber","018e6c42-81c4-79eb-823c-9419139e1090","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269301,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-81c7-732a-b5b5-95183ace0245-1234-$record.itemnumber","018e6c42-81c7-732a-b5b5-95183ace0245","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269141,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-81d1-7c04-add6-d0b722b66557-1234-$record.itemnumber","018e6c42-81d1-7c04-add6-d0b722b66557","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269131,Response to Health Authority,msw12,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-81da-735f-a3b1-2c7904bdda29-1234-$record.itemnumber","018e6c42-81da-735f-a3b1-2c7904bdda29","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269081,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-81db-7c52-a74d-701e5ed47670-1234-$record.itemnumber","018e6c42-81db-7c52-a74d-701e5ed47670","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269021,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-81db-7efb-ad7f-7355e4ebf3ce-1234-$record.itemnumber","018e6c42-81db-7efb-ad7f-7355e4ebf3ce","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269051,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e6c42-81e3-7343-b4f7-e900077901fe-1234-$record.itemnumber","018e6c42-81e3-7343-b4f7-e900077901fe","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269071,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e7168-d783-7a01-ab3c-3dfc9535b6c8-1234-$record.itemnumber","018e7168-d783-7a01-ab3c-3dfc9535b6c8","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269101,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018e7168-d783-7fd3-8029-9f6ca4fc0a9e-1234-$record.itemnumber","018e7168-d783-7fd3-8029-9f6ca4fc0a9e","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269111,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91e8-7826-9b81-ba2e82d842f6-1234-$record.itemnumber","018eb45b-91e8-7826-9b81-ba2e82d842f6","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269311,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,JNJ-61186372-AAA,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91ec-7875-9f0d-01adaa9eec7e-1234-$record.itemnumber","018eb45b-91ec-7875-9f0d-01adaa9eec7e","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1281551,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91ec-7d7e-a6be-0db60653c176-1234-$record.itemnumber","018eb45b-91ec-7d7e-a6be-0db60653c176","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1272061,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91ed-733c-8dbc-70dbfd670d47-1234-$record.itemnumber","018eb45b-91ed-733c-8dbc-70dbfd670d47","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269211,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91ed-7e7b-952a-5c7343bb7933-1234-$record.itemnumber","018eb45b-91ed-7e7b-952a-5c7343bb7933","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1272071,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91f0-7432-bfbc-e9f088fdb7a1-1234-$record.itemnumber","018eb45b-91f0-7432-bfbc-e9f088fdb7a1","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1281561,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91f1-75bb-b7ac-4cb2186ffa9b-1234-$record.itemnumber","018eb45b-91f1-75bb-b7ac-4cb2186ffa9b","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269181,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91f2-75e3-abe0-5a1edc46cd66-1234-$record.itemnumber","018eb45b-91f2-75e3-abe0-5a1edc46cd66","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269221,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,JNJ-61186372-AAA,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91f9-7b98-a5a0-a1063c67e101-1234-$record.itemnumber","018eb45b-91f9-7b98-a5a0-a1063c67e101","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1281591,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91fb-7806-83d9-90755c561c97-1234-$record.itemnumber","018eb45b-91fb-7806-83d9-90755c561c97","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1281531,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91fc-79c4-87bc-10fa781188f1-1234-$record.itemnumber","018eb45b-91fc-79c4-87bc-10fa781188f1","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269191,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-91ff-7b2e-b044-abc4caf743e3-1234-$record.itemnumber","018eb45b-91ff-7b2e-b044-abc4caf743e3","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1281541,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-9202-719a-9d4e-1c115d10a8f4-1234-$record.itemnumber","018eb45b-9202-719a-9d4e-1c115d10a8f4","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1281571,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb45b-9203-7d6a-abac-38e32c3f04a9-1234-$record.itemnumber","018eb45b-9203-7d6a-abac-38e32c3f04a9","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269271,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb981-ed9c-7ddf-b648-e9966886e616-1234-$record.itemnumber","018eb981-ed9c-7ddf-b648-e9966886e616","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269261,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb981-ed9c-7ec4-a9cb-70ab8617e6bc-1234-$record.itemnumber","018eb981-ed9c-7ec4-a9cb-70ab8617e6bc","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269241,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb981-eda0-707f-bcde-71624e277efd-1234-$record.itemnumber","018eb981-eda0-707f-bcde-71624e277efd","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269171,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018eb981-eda4-7acd-8fae-1b516aec8d4f-1234-$record.itemnumber","018eb981-eda4-7acd-8fae-1b516aec8d4f","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269201,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018f9977-9787-7669-bc02-9afb97658b0f-1234-$record.itemnumber","018f9977-9787-7669-bc02-9afb97658b0f","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1306811,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018f9977-979a-78e4-a72f-1001e36095fe-1234-$record.itemnumber","018f9977-979a-78e4-a72f-1001e36095fe","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1306821,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018f9977-98d4-7b9c-97bc-de344e7a51da-1234-$record.itemnumber","018f9977-98d4-7b9c-97bc-de344e7a51da","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1325421,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-018f9977-990c-7b5b-bdb4-672b1cd6bb4d-1234-$record.itemnumber","018f9977-990c-7b5b-bdb4-672b1cd6bb4d","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1324351,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7464-7e89-b56c-965c5d03a49d-1234-$record.itemnumber","019274cc-7464-7e89-b56c-965c5d03a49d","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1412261,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-74a2-7fd2-8f0d-4cce687f332d-1234-$record.itemnumber","019274cc-74a2-7fd2-8f0d-4cce687f332d","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1344121,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7628-7dfc-840f-60131d5449cd-1234-$record.itemnumber","019274cc-7628-7dfc-840f-60131d5449cd","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1394431,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-77d3-74c4-9e6f-a47961bddefb-1234-$record.itemnumber","019274cc-77d3-74c4-9e6f-a47961bddefb","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1344181,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,JNJ-61186372-AAA,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7876-7a16-a8ea-4e36ecd5747e-1234-$record.itemnumber","019274cc-7876-7a16-a8ea-4e36ecd5747e","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1419811,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-78ff-74fe-b7fc-0e3e2163f82b-1234-$record.itemnumber","019274cc-78ff-74fe-b7fc-0e3e2163f82b","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1384521,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,JNJ-61186372-AAA,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7949-7749-ab1b-c32c0d03fda4-1234-$record.itemnumber","019274cc-7949-7749-ab1b-c32c0d03fda4","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269281,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-79fb-7c31-806a-dd9aba3a8943-1234-$record.itemnumber","019274cc-79fb-7c31-806a-dd9aba3a8943","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269161,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7a1a-7c77-b58d-f9fac13b7c51-1234-$record.itemnumber","019274cc-7a1a-7c77-b58d-f9fac13b7c51","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1384531,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7a69-7026-81b1-68c1ea63351c-1234-$record.itemnumber","019274cc-7a69-7026-81b1-68c1ea63351c","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1384511,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7a6a-72de-84d7-1118edb41e71-1234-$record.itemnumber","019274cc-7a6a-72de-84d7-1118edb41e71","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1377051,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7a6e-7937-afcb-5ec9da4d94a4-1234-$record.itemnumber","019274cc-7a6e-7937-afcb-5ec9da4d94a4","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1393161,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7ab0-702c-b61b-d347ae671596-1234-$record.itemnumber","019274cc-7ab0-702c-b61b-d347ae671596","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269251,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7afd-7922-be27-8596a5b38c81-1234-$record.itemnumber","019274cc-7afd-7922-be27-8596a5b38c81","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1269291,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7c48-710e-8dd8-05ba2ca97092-1234-$record.itemnumber","019274cc-7c48-710e-8dd8-05ba2ca97092","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1377041,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7c69-7ee2-b2cf-bb8bf55c97bc-1234-$record.itemnumber","019274cc-7c69-7ee2-b2cf-bb8bf55c97bc","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1412221,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-019274cc-7c6d-7bc2-9e9c-c3a4e9eaa4f1-1234-$record.itemnumber","019274cc-7c6d-7bc2-9e9c-c3a4e9eaa4f1","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1412231,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-0196a355-98bb-7cbc-91d5-ef7e83e0bdb3-1234-$record.itemnumber","0196a355-98bb-7cbc-91d5-ef7e83e0bdb3","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1568411,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"JP,ASIA",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-0196a355-98f0-71ab-8c40-f75343e3429b-1234-$record.itemnumber","0196a355-98f0-71ab-8c40-f75343e3429b","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1556911,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"JP,ASIA",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,JNJ-61186372-AAA,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-0196a355-98f8-742e-9338-c8c2fe24acfd-1234-$record.itemnumber","0196a355-98f8-742e-9338-c8c2fe24acfd","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1569251,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-0196a355-9a29-7bc1-92c6-148e01860ff4-1234-$record.itemnumber","0196a355-9a29-7bc1-92c6-148e01860ff4","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1507441,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-0196a355-9b0f-7ab2-a895-16eda61d3246-1234-$record.itemnumber","0196a355-9b0f-7ab2-a895-16eda61d3246","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1556901,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"JP,ASIA",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-0196a355-9f3a-7ecf-8b33-49d7702c637f-1234-$record.itemnumber","0196a355-9f3a-7ecf-8b33-49d7702c637f","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1598991,Response to Health Authority,pdf,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-0196a355-a0ff-7979-b7a2-2adea27e992b-1234-$record.itemnumber","0196a355-a0ff-7979-b7a2-2adea27e992b","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1601621,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,JNJ-61186372-AAA,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-0637b8c6-228d-4c43-8c5b-8b8108256580-1234-$record.itemnumber","0637b8c6-228d-4c43-8c5b-8b8108256580","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-795991,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-16957fdd-4297-4344-bae8-8f955475926a-1234-$record.itemnumber","16957fdd-4297-4344-bae8-8f955475926a","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-ERI-172878001,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"JP,ASIA",Regulatory Administrative Information,NA,"amivantamab,amivantamab","RYBREVANT,RYBREVANT,NOT AVAILABLE,NOT AVAILABLE","CNTO4424,JNJ-61186372-AAA,JNJ-61186372,JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-3b9e27cf-af87-41e1-93c4-dec5ed5ec08a-1234-$record.itemnumber","3b9e27cf-af87-41e1-93c4-dec5ed5ec08a","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-ERI-154420891,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"JP,ASIA",Regulatory Administrative Information,NA,"amivantamab,amivantamab","RYBREVANT,RYBREVANT,NOT AVAILABLE,NOT AVAILABLE","JNJ-61186372-AAA,CNTO4424,CNTO4424,JNJ-61186372,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-42c30c31-7ab4-459d-8327-c264832caca4-1234-$record.itemnumber","42c30c31-7ab4-459d-8327-c264832caca4","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-680921,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-53bccaa0-22d5-4844-ad5c-f610862b993b-1234-$record.itemnumber","53bccaa0-22d5-4844-ad5c-f610862b993b","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-796001,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372-AAA,JNJ-61186372,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-5f30d04d-8346-46f8-82d1-7fa1e6074ec0-1234-$record.itemnumber","5f30d04d-8346-46f8-82d1-7fa1e6074ec0","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-773711,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-79119b54-a8d8-4ce5-8b16-0ee2336ac2d6-1234-$record.itemnumber","79119b54-a8d8-4ce5-8b16-0ee2336ac2d6","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1244231,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,"amivantamab,amivantamab","RYBREVANT,NOT AVAILABLE,RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA,JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-7cd35712-6389-410e-bc4c-d618f76cd20d-1234-$record.itemnumber","7cd35712-6389-410e-bc4c-d618f76cd20d","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-ERI-154420321,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"JP,ASIA",Regulatory Administrative Information,NA,"amivantamab,amivantamab","RYBREVANT,NOT AVAILABLE,NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,CNTO4424,JNJ-61186372-AAA,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-927131f6-e926-4a50-ae78-497d32eebe7f-1234-$record.itemnumber","927131f6-e926-4a50-ae78-497d32eebe7f","01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-697641,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,CNTO4424,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-db541fb0-5c91-41fe-956e-932d029a03d5-1234-$record.itemnumber",db541fb0-5c91-41fe-956e-932d029a03d5,"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-773731,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"RYBREVANT,NOT AVAILABLE","JNJ-61186372,JNJ-61186372-AAA,CNTO4424",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-df1d1e6d-cc49-40b2-a3e3-1092e38a6895-1234-$record.itemnumber",df1d1e6d-cc49-40b2-a3e3-1092e38a6895,"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-807851,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372,JNJ-61186372-AAA",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-e9c9b173-70ff-4065-ac97-c31be5ddcd8a-1234-$record.itemnumber",e9c9b173-70ff-4065-ac97-c31be5ddcd8a,"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-773701,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-ed6507bf-e38a-4079-8195-87dcc62b74e2-1234-$record.itemnumber",ed6507bf-e38a-4079-8195-87dcc62b74e2,"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1259241,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","JNJ-61186372-AAA,CNTO4424,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-ed6be27d-539b-4380-a8e7-353293533325-1234-$record.itemnumber",ed6be27d-539b-4380-a8e7-353293533325,"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-773721,Response to Health Authority,msw15,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a-fd68d819-c588-4360-9e62-a3feec472dc7-1234-$record.itemnumber",fd68d819-c588-4360-9e62-a3feec472dc7,"01966ca2-7ddd-7085-bc3d-0966f1ce7f5a",CypressTC2 – Streamer Test,"1234",2025-05-08 00:00:00.000,EDMS-RIM-1198411,Response to Health Authority,msw14,JNJ-61186372,"",Responses to Questions,"ASIA,JP",Regulatory Administrative Information,NA,amivantamab,"NOT AVAILABLE,RYBREVANT","CNTO4424,JNJ-61186372-AAA,JNJ-61186372",Approved
